EuroSIDA Publications 2024

  1. Differences in integrated assessment and management of non-communicable diseases (NCDs) for people with HIV across the WHO European region. Kraef C, Singh S, Fursa O, Abutidze A, Rukhadze N, Mulabdic V, Yancheva N, Mehmeti M, Balayan T, Harxhi A, Trajanovska J, Mackintosh C, Duvivier C, Beniowski M, Jilich D, Reikvam DH, Tau L, Podlekareva D, Ryom L, Peters L, Kowalska J, Kirk O; EuroSIDA Study Group.
    HIV Med. 2024. Epub ahead of print. Abstract
     

  2. SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort. Fursa O, Bannister W, Neesgaard B, Podlekareva D, Kowalska J, Benfield T, Gerstoft J, Reekie J, Rasmussen LD, Aho I, Guaraldi G, Staub T, Miro JM, Laporte JM, Elbirt D, Trofimova T, Sedlacek D, Matulionyte R, Oprea C, Bernasconi E, Hadžiosmanović V, Mocroft A, Peters L; EuroSIDA Study Group.
    HIV Med. 2024. Epub ahead of print. Abstract
     

  3. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts. Byonanebye DM, Polizzotto MN, Maltez F, Rauch A, Grabmeier-Pfistershammer K, Wit F, De Wit S, Castagna A, d'Arminio Monforte A, Mussini C, Wasmuth JC, Fontas E, Abela I, Sarcletti M, Bansi-Matharu L, Jaschinski N, Peters L, Hosein SR, Vannappagari V, Cohen C, Bissio E, Mocroft A, Law M, Ryom L, Petoumenos K; RESPOND study group.
    Lancet HIV. 2024;11(5):e321-e332. Abstract
     

  4. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration. Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study.
    Clin Infect Dis. 2024:ciae228. Abstract
     

  5. All-cause and AIDS-related mortality among people with HIV across Europe from 2001 – 2020: impact of antiretroviral therapy, and regional differences in a multicentre cohort study Kraef C, Tusch E, Singh S, Østergaard L, Fätkenheuer G, Castagna A, Moreno S, Kusejko K, Szetela B, Kuznetsova A, Tomažič J, Ranin J, Zangerle R, Mansson F, Marchetti G, De Wit S, Clarke A, Gerstoft J, Podlekareva D, Peters L, Reekie J, Kirk O, and the EuroSIDA Study Group.
    The Lancet Regional Health - Europe 2024;44: 100989. Abstract
     

  6. Chronic liver enzyme elevation and use of contemporary ARVs among people with HIV. Roen AO, Peters L, Wandeler G, van der Valk M, Zangerle R, Günthard HF, Wit F, Mussini C, De Wit S, d’Arminio Monforte A, Vehreschild JJ, Castagna A, Jaschinski NJ, Vannappagari V, Chen L, Tallada J, C’mar J, Mocroft A, Ryom L.
    Open Forum Infectious Diseases, 2024. Abstract
     

  7. Integrase strand transfer inhibitor (INSTI) related changes in BMI and risk of diabetes: a prospective study from the RESPOND cohort consortium. Rupasinghe D, Bansi-Matharu L, Law M, Zangerle R, Rauch A, Tarr PE, Greenberg L, Neesgaard B, Jaschinski NJ, De Wit S, Wit F, d'Arminio Monforte A, Fontas E, Castagna A, Stecher M, Brandes V, Florence E, Begovac J, Mussini C, Sönnerborg A, Abutidze A, Groh A, Vannappagari V, Cohen C, Young L, Hosein S, Ryom L, Petoumenos K.
    Clin Infect Dis.2024:ciae406. Abstract
     

  8. Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in Europe. Johansen IS, Roen A, Kraef C, Martín-Iguacel R, Nemeth J, Fenner L, Zangerle R, Llibre JM, Miller RF, Suarez I, de Wit S, Wit F, Mussini C, Saracino A, Canetti D, Volny-Anne A, Jaschinski NJ, Neesgaard B, Ryom L, Peters L, Garges HP, Rooney JF, Podlekareva D, Mocroft A, Kirk O; RESPOND Study group.
    Int J Infect Dis.2024. Abstract
      

  9. Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men. Hutchinson J, Neesgard B, Kowalska J, Grabmeier-Pfistershammer K, Johnson M, Kusejko K, De Wit S, Wit F, Mussini C, Castagna A, Stecher M, Pradier C, Domingo P, Carlander C, Wasmuth J, Chkhartishvili N, Uzdaviniene V, Haberl A, d'Arminio Monforte A, Garges H, Gallant J, Said M, Schmied B, van der Valk M, Konopnicki D, Jaschinski N, Mocroft A, Greenberg L, Burns F, Ryom L, Petoumenos K.
    HIV Med. 2024;25(9):1058-1074. Abstract
     

 

Total Publications December 2024: 346